Showing results (411-420 of 651) with videos related to
Sort By:
Pageof 66
Journal of the American Heart Association|July 19, 2021
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE TrialMikkel Jürgens, Morten Schou, Philip Hasbak, et al.Cardiovascular Diabetology|April 8, 2018
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuriaGemma E Currie, Bernt Johan von Scholten, Sheon Mary, et al.BMJ Open|June 6, 2023
Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)Marie Møller, Rikke Borg, Iain Bressendorff, et al.Kidney International|May 26, 2026
The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic SyndromeAdeera Levin, Nisha Bansal, Ian H de Boer, et al.Plos One|March 3, 2021
Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuriaSigne Abitz Winther, Jens Christian Øllgaard, Tine Willum Hansen, et al.Diabetes Care|April 13, 2018
Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and MicroalbuminuriaDaniel G K Rasmussen, Tine W Hansen, Bernt J von Scholten, et al.BMJ Open|November 30, 2019
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.Diabetes Care|January 19, 2023
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover TrialViktor Rotbain Curovic, Niels Jongs, Marjolein Y A M Kroonen, et al.Journal of Diabetes and Its Complications|November 25, 2025
Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney functionShigehiro Katayama, Stefan D Anker, Dalong Zhu, et al.Nephron|January 11, 2023
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney DiseaseTherese Adrian, Mads Hornum, Filip Krag Knop, et al.Pageof 66